{"id":"W2979864420","doi":"10.1182/blood.v116.21.111.111","title":"Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (<61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Rituximab; Medicine; Regimen; Internal medicine; CHOP; Clinical endpoint; Chemotherapy regimen; Diffuse large B-cell lymphoma; Surgery; Oncology; Randomized controlled trial; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002623559,0.001967938,0.003364636,0.0004746393,0.0006394915,0.001297268,0.001120702,0.002756221,0.007599588],"category_scores_gemma":[0.002860903,0.0008565171,0.002304786,0.0004028119,0.001457819,0.001406869,0.0008016702,0.004206204,0.001269947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009593382,"about_ca_system_score_gemma":0.001339358,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001413922,"about_ca_topic_score_gemma":0.003483698,"domain_scores_codex":[0.999043,0.0005963586,0.0000386768,0.0001344539,0.00005386174,0.0001335414],"domain_scores_gemma":[0.9983041,0.0004323895,0.0003482657,0.0002085881,0.00008026916,0.0006264304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9932934,0.002092039,0.0003085308,0.0001224482,0.0003315859,0.00002034091,0.00002517822,0.0001240389,0.0006051488,0.00008381167,0.0004716494,0.002521927],"study_design_scores_gemma":[0.9836294,0.01501781,0.0005531947,0.00001354621,0.0001688396,0.00001209855,0.000009033338,0.0001237967,0.00008081465,0.0001149612,0.0002700072,0.000006543044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771976,0.003787413,0.0008164701,0.00237,0.002250135,0.00717326,0.002690804,0.0001232601,0.003591115],"genre_scores_gemma":[0.9656755,0.002381793,0.002531527,0.005078735,0.001526655,0.01266585,0.002909415,0.00004128297,0.007189233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007599588,"threshold_uncertainty_score":0.02542317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006993248135219416,"score_gpt":0.2434403757630418,"score_spread":0.2364471276278224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}